Clinical Trials
11 trialsNCT07558447 2026-04-30
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase NA Recruiting
NCT04583124 2025-11-18
ATENTO
Universidad de Granada
Phase NA Completed
NCT00039780 2022-07-13
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
BioNumerik Pharmaceuticals, Inc.
Phase 3 Completed
NCT02864030 2021-03-04
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4 Completed
NCT01050075 2017-11-06
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel
City of Hope Medical Center
Phase NA Terminated
NCT00754767 2017-09-11
L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer
HealthPartners Institute
Phase 4 Terminated
NCT00775645 2017-08-14
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo
SWOG Cancer Research Network
Phase 3 Completed
NCT00046891 2016-07-06
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01763710 2016-03-29
neurabrax
Fundacion Oncosur
Phase 2 Completed
NCT00301080 2013-12-02
D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain
Northwestern University
Phase 3 Terminated
NCT00078845 2012-10-17
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Completed